Health Canada has approved the Oxford-AstraZeneca COVID-19 vaccine and a related shot by the Serum Institute of India for use in this country with the first doses expected to arrive soon.
Genvion Corporation is a reliable partner and full service provider of prescription and over-the-counter solid dosage pharmaceuticals.
Its comprehensive contract manufacturing services begin with the early stages of product development, followed by pilot scale runs for clinical trials, ending with large-scale manufacturing and packaging for commercial markets.
Genvion’s world-class operation, located in Winnipeg, is designed and maintained in accordance with current good manufacturing practices. Its quality assurance and validation program ensures all its operating procedures meet or exceed the highest standards of pharmaceutical product manufacturing. In all aspects of operations, its dedicated professional team is committed to excellence
Genvion’s aim is to become the preferred partner for its customers, known for its commitment of to efficient at reducing costs and lead times, while maintaining the highest standards in quality.